筛查结肠镜检查中的息肉特征与结肠镜检查后结直肠癌死亡率:一项回顾性队列研究
该回顾性研究纳入奥地利筛查结肠镜质量认证项目2007年1月至2020年12月期间接受结肠镜检查的316001人,中位随访5.27年,分析息肉大小和异型增生与结肠镜检查后结直肠癌(PCCRC)死亡的关系。结果显示10至20毫米息肉(HR 4.00)及高级别异型增生(HR 6.61)与PCCRC死亡显著相关;息肉<10毫米且无高级别异型增生者PCCRC死亡率显著低于一般人群预期(SMR 0.27),而息肉≥10毫米或伴高级别异型增生者未见此现象(SMR 2.05)。
要点
- 筛查结肠镜发现10至20毫米息肉与PCCRC死亡显著相关(HR 4.00)。
- 高级别异型增生与PCCRC死亡显著相关(HR 6.61)。
- 息肉<10毫米且无高级别异型增生者PCCRC死亡率低于一般人群预期(SMR 0.27)。
核心结论
- 息肉大小≥10毫米和高级别异型增生与筛查患者的PCCRC死亡率相关。
- 数据提示这些患者可能从监测结肠镜检查中获益最多。
研究设计与样本
- 回顾性研究,纳入奥地利筛查结肠镜质量认证项目中2007年1月至2020年12月期间接受结肠镜检查的个体。
- 共纳入316001人,中位随访5.27年(95%CI 5.25-5.29)。
- 采用Cox回归分析评估息肉大小和异型增生与PCCRC死亡的关联,并计算标准化死亡比(SMR)与奥地利一般人群比较。
主要发现
- 10至20毫米息肉与PCCRC死亡显著相关(HR 4.00;95%CI 2.46-6.50;P<.001)。
- 高级别异型增生与PCCRC死亡显著相关(HR 6.61;95%CI 3.31-13.2;P<.001)。
- 息肉<10毫米且无高级别异型增生者PCCRC死亡率显著低于一般人群预期CRC死亡率(SMR 0.27;95%CI 0.21-0.33;P<.001)。
- 息肉≥10毫米或伴高级别异型增生者未观察到PCCRC死亡率低于一般人群预期(SMR 2.05;95%CI 1.64-2.57;P<.001)。
临床怎么用
- 原文结论未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Polyp size and high-grade dysplasia in polyps at screening colonoscopy are considered risk factors for post-colonoscopy colorectal cancer (PCCRC) development and death, which might be averted by surveillance colonoscopy. However, robust evidence backing these risk factors is lacking. We aimed to investigate whether polyp size or dysplasia grade is associated with PCCRC mortality. METHODS: This was a retrospective study including individuals of the Austrian Quality Certificate for Screening Colonoscopy who underwent a colonoscopy between January 2007 and December 2020. We investigated the association of polyp size and dysplasia in polyps with PCCRC mortality according to Cox regression analysis. In addition, whether patients with certain polyp characteristics had similar risk for CRC death compared with the Austrian population was assessed by calculating standardized mortality ratios (SMRs). RESULTS: A total of 316,001 individuals were included. After a median follow-up time of 5.27 years (95% confidence interval [CI], 5.25-5.29), a significant association of polyps 10 to 20 mm (hazard ratio, 4.00; 95% CI, 2.46-6.50; P < .001) as well as high-grade dysplasia (hazard ratio, 6.61; 95% CI, 3.31-13.2; P < .001) with PCCRC death was observed. PCCRC mortality was significantly lower than the expected CRC mortality in the general population in patients with polyps <10 mm and without high-grade dysplasia (SMR, .27; 95% CI, .21-.33; P < .001), which was not observed for patients with polyps ≥10 mm or with high-grade dysplasia (SMR, 2.05; 95% CI, 1.64-2.57; P < .001). CONCLUSIONS: Polyp size ≥10 mm and high-grade dysplasia are associated with PCCRC mortality in screening patients. The data suggest that these patients might benefit most from surveillance colonoscopy.
引用
- Zessner-Spitzenberg J, Jiricka L, Waldmann E, et al. Polyp characteristics at screening colonoscopy and post-colonoscopy colorectal cancer mortality: a retrospective cohort study. Gastrointest Endosc. 2023. PMID: 36649747. doi:10.1016/j.gie.2023.01.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。